Big Tech’s patent battering ram isn’t lowering drug prices

Big Tech and its newfound allies are adopting a novel line of attack in their war against the patent system. These days, they’re latching on to Americans’ outrage over high drug prices to create a new enemy in their anti-patent jihad.

Big Tech’s manufactured crusade against so-called patent trolls, which it portrays as preying on everyday businesses, is well documented. It was a storyline Big Tech hammered relentlessly en route to convincing Congress to pass the America Invents Act of 2011, a law that created the Patent Trial and Appeal Board, or PTAB.